Side Effects Page #5

not initiate any discussion.

(voice over) There is to be no discussion between

the reps and the physicians on this topic.

(voice over) The possibilities are limitless for a rep

like you.

(voice over) You've worked so hard for this, you're

so close.

(voice over) Do you know how much money you,

personally, have the potential to make with this

drug?

(voice over) Have I made myself clear? You've

worked so hard for this.

(voice over) I'd hate to see you fall of the ladder

before you reach the final rung.

(voice over) Have I made myself clear? There is

to be no discussion between the reps and the

physicians on this topic.

(voice over) Think about it.

(screech)

Medical services please.

Are you a physician?

Yes.

Name please?

Dr. Joyce Briggs.

Address?

Um, 201 Williams St., Madison, Wisconsin.

One moment please.

Transferring you now to medical services.

(ring)

Medical Services, may I help you?

Yes, I was one of the psychiatrists who received a

preliminary sample of Vivexx to try.

I was wondering if there were any concerns with

this drug in relation to liver issues.

One moment please.

The package insert contains no precautions,

warnings or contraindications in this area.

It should not be an issue in your patients.

But wasn't there a case report that said...

The case report that was published was not

conclusive. There was no way to rule out other

factors.

As you know this is a very difficult patient

population to gauge.

We are not recommending any additional liver

monitoring.

Thank you.

(Knock, knock, knock)

Come in.

Dr. Feinstein, I'm Karly Hert from Braden-

Andrews.

Wow.

Huh?

I never would've thought that Braden-Andrews

would send a rep to talk to me again.

I'm not sure I understand what you mean.

Let's just say that I have fallen out of favor with

the one who sends your paycheck.

How so?

Why are you here?

Vivexx is gearing up to launch and I thought since

you were involved in some of the research...

I guess I just thought you would be a good

starting point.

Ah yes, the golden cow, Vivexx. (chuckling)

If you are here to try and convince me to use it,

you're wasting your breath.

Why wasn't your name listed as one of the

authors for the journal of psychiatry study?

Why would it be?

Because it was listed as one of the original

authors for the poster presentation at last year's

psychiatric association meeting.

That is a very interesting thing for you to notice.

Why?

Did you take a look at the section on side effects

and safety?

Yes. It mentioned some mild sedation and teeth

grinding.

It's more what that section does not say, than

what it does.

I don't understand.

I learned a very long time ago to be extremely

cautious about using new meds on patients, even

throughout the course of a study.

Now, I decided as a precautionary note to monitor

liver enzymes in patients who began taking

Vivexx.

My site enrolled 112 patients, 26 of them

experienced significant elevation of the enzyme

upon taking Vivexx.

All 26 returned to normal readings upon

discontinuation.

Why isn't that information listed here?

They conveniently found a way to disqualify my

site, therefore all my findings were thrown out.

Ours was the only study site monitoring liver

function.

Now the poster presentation at the AAPA was just

to show preliminary efficacy findings.

By the time the study was published, I and my

data had been removed.

There were others.

Excuse me?

Would you be willing to help me with something?

Oh, I'm sorry.

(voice over) You're one of us now! We're thinking

management. You need to reevaluate the way you

dress.

(voice over) You're one of us now! We're thinking

management. You need to reevaluate the way you

dress.

(voice over) Are you on board here Karly? You

will notice this is quite a conservative company.

I'm going to have to reschedule with Dr. Jones.

No problem, just let me check the schedule.

I'm ready for you now Karly.

Oh God, I can't.

What the hell?

Oh God Dammit! (Screaming!!!!)

(Knock, knock, knock)

Hello Dr. Sweeney, mind if I ask you a few

questions?

Absolutely, come on in.

So what would you say your opinion is of

pharmaceutical sales representatives?

I love the sales reps.

I think they do a great job, they give me the

information I need fast.

I depend on them to give me facts regarding the

drugs they sell.

And besides, there's nothing like a free lunch now

and then, is there?

The healthcare sector made some significant

gains in the biotech and pharmaceutical markets.

Braden-Andrews stock skyrocketed today, as they

received FDA approval for the much-anticipated,

anti-depressant Vivexx.

It is anticipated that Vivexx may be the

blockbluster of the century.

In other business news today Wall Street is

braced for this quarters report on consumer

confidence.

Analysts project a dip indicated by early holiday

shopping...

Dobson, Sally Dobson.

# Can't be seen. Can't be heard. Is this a

dream?

What's the matter sweetie? This is a big night for

you.

You know you can tell me anything.

It's probably nothing.

But I was just wondering what your take was on

some of the liver issues with Vivexx?

I have no take, because there is no issue.

You're right. It's just that everything has been

happening so fast.

You're right.

Good. Now let's go have some fun.

To Vivexx!

To Vivexx.

Well folks, it's that time in of the evening to honor

our industry's "Rep of the Year".

Each year we present this award to the

pharmaceutical representative who has had...

...the greatest impact educating physicians and

thereby improving patient quality of life.

Each company nominates one representative who

exemplifies these outstanding qualities.

Please join me in a round of applause, as I invite

Peter Anderson...

President of Braden-Andrews, to introduce this

year's winner.

Peter?

(applause)

Thanks, Mike.

(applause)

(applause)

This year, it is my honor to present this award to a

rep...

who exemplifies everything that our company

stands for.

She is hard working, intelligent, and did I mention

that this kid can move market share?

(Laughter)

But most importantly, her #1 goal is the same as

our own:
To protect and prolong human life.

Karly Hert, it is my honor to present to you this

year's

Pharmaceutical Industry Rep of the Year Award.

(applause)

See, my Reps are good.

(applause)

(heartbeat) dum dum, dum dum

Thank you.

Thank you.

Many people have asked me what my secret is.

How can you have that kind of relationship with

physicians?

How can you move that kind of market share?

The answer is simple, really.

Honesty.

Honesty with physicians, staff,

and myself.

Thus in the spirit of honesty and to live out the

Braden-Andrews creed...

to protect and prolong human life.

I'd like to introduce someone.

Sally Dobson, would you please join me?

Dobson.

Thank you so much Karly,

I want to share a story with everyone about one

Rate this script:0.0 / 0 votes